Jaguar Health (NASDAQ:JAGX) | Finanzwire

Basculer en Français

10162	Companies
208752	Keywords
138863	Articles
110650	Press releases

Home
Companies
Jaguar Health

BRIEF

published on 07/18/2024 at 16:35, 1 year 8 months ago

Jaguar Health to Report Phase 3 OnTarget Trial Results for Crofelemer on July 23rd

Crofelemer Webcast Jaguar Health OnTarget Trial Cancer Supportive Care
PRESS RELEASE

published on 07/18/2024 at 16:30, 1 year 8 months ago

Jaguar Health to Report Phase 3 OnTarget Trial Results for Its Cancer Supportive Care Drug Crofelemer on July 23rd and Hold Investor Webcast that Morning
Jaguar Health announces webcast for cancer supportive care updates including OnTarget trial results. Make Cancer Less Shitty program expands with MCLS Ambassadors

Webcast Jaguar Health OnTarget Trial Cancer Supportive Care Make Cancer Less Shitty
BRIEF

published on 07/08/2024 at 16:35, 1 year 8 months ago

Jaguar Health Strengthens IP Protection with New European and Australian Patents

Crofelemer Jaguar Health Australian Patent European Patent SBS And CDDs
PRESS RELEASE

published on 07/08/2024 at 16:30, 1 year 8 months ago

Issuance of New European & Australian Patents Bolster IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDDs)
New patents issued for core rare disease target indications for crofelemer. Jaguar Health announces new patents from European Patent Office and IP Australia for Napo Pharmaceuticals' crofelemer. Expected results in 2024 and 2025

Napo Pharmaceuticals Crofelemer Jaguar Health Patents Rare Disease

Accesswire

Published on 04/02/2026 at 22:00, 3 days 13 hours ago

Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 3 days 16 hours ago

Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 3 days 20 hours ago

Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 3 days 20 hours ago

Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 3 days 20 hours ago

Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution

View all ACCESSWIRE

EQS Group

Published on 04/06/2026 at 10:05, 1 hour 18 minutes ago

K-679: A Novel Antibody Drug-loaded Unimicelle Conjugate Demonstrates Tumor-Selective Pharmacokinetics, Extensive Intratumoral Distribution and Superior Efficacy in Non-Clinical Animal Models
Published on 04/06/2026 at 09:05, 2 hours 18 minutes ago

McDonald's Türkiye Launches Campaign Spotlighting Driving Safety
Published on 04/04/2026 at 10:07, 2 days 1 hour ago

Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
Published on 04/04/2026 at 02:05, 2 days 9 hours ago

Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products
Published on 04/03/2026 at 18:00, 2 days 17 hours ago

IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL

Les Echos

Published on 04/03/2026 at 18:46, 2 days 16 hours ago

Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 17:45, 2 days 17 hours ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 04/03/2026 at 17:45, 2 days 17 hours ago

Information concerning the total number of voting rights and shares 2026 03 31
Published on 04/03/2026 at 17:45, 2 days 17 hours ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 04/03/2026 at 17:45, 2 days 17 hours ago

March 2026

View all LES ECHOS COMFI WIRE